期刊文献+

UPLC-MS/MS测定犬血浆中的氢溴酸加兰他敏

Determination of Galanthamine hydrobromide in the dog plasma by UPLC-MS/MS
原文传递
导出
摘要 目的采用超高效液相色谱-串联质谱法测定犬血浆中氢溴酸加兰他敏(GH)的含量。方法采用BEH C18色谱柱(50 mm×2.1 mm,1.7μm),流动相为乙腈-0.01 mol·L-1醋酸铵(含0.1%甲酸)(40∶60),流速0.1 mL·min-1,柱温40℃,进样量3μL。GH及内标盐酸克仑特罗的监测离子分别为:m/z 288.23→198.06,m/z 277.08→202.93。结果 GH的线性范围为2.38~609.60μg·L-1(r=0.998,n=5),在人血浆基质中,高、中、低浓度(4.76、38.10、304.80μg·L-1)的日内、日间RSD均小于15%,方法的平均回收率为102.3%;血浆基质对测定无干扰。结论所建方法处理简单、快速、灵敏、特异性高,定量准确,适用于血浆中GH的测定。 OBJECTIVE To establish a selective and sensitive UPLC-MS/MS method for determination of Galanthamine hydrobromide in the dog plasma.METHODS BEH C18(50 mm×2.1 mm,1.7 μm)was used as the solid phase,the mobile phase consisted of acetonitrile-0.01 mol·L-1 ammonium acetate(contained 0.1% formic acid)(40:60).The flow rate was 0.1 mL·min-1,column temperature was 40 ℃,and inject volume was 3 μL.The monitoring ion of Galanthamine hydrobromide and internal standard clenbuterol hydrochloride was m/z 288.23→198.06,m/z 277.08→202.93,respectively.RESULTS A good linearity was shown in the range of 2.38-609.60 μg·L-1(r=0.998,n=5).The average recovery was 102.3% with intra-day RSD and inter-day RSD less than 15%.Plasma matrix had no effect on quantification of Galanthamine hydrobromide.CONCLUSION A simple,rapid,sensitive,selective and accurate UPLC-MS method was developed for the determination of Galanthamine hydrobromide in plasma.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第3期321-323,共3页 West China Journal of Pharmaceutical Sciences
关键词 氢溴酸加兰他敏缓释胶囊 超高效液相色谱-串联质谱法 含量测定 Galanthamine hydrobromide release capsule UPLC-MS/MS Determination
  • 相关文献

参考文献5

二级参考文献18

  • 1吕雄文,李俊,徐元宏,金涌,李元海,彭磊,葛金芳.单剂量与多剂量口服罗红霉素缓释片与普通片的犬体药物动力学研究[J].中国药理学通报,2004,20(7):811-814. 被引量:5
  • 2张继稳,钟大放,毕殿洲.单室模型药物血管外给药零级、一级释放药物动力学[J].中国药理学通报,2005,21(2):245-248. 被引量:10
  • 3Scott L J,Goa K L.Galanthamine:a review of its use in Alzheimers disease[J].Drugs,2000,60(5):1095-122. 被引量:1
  • 4Thompson C A.FDA approves galantamine for Alzheimer's disease[J].Am J Health Syst Pharm,2001,58(8):649-650. 被引量:1
  • 5Verhaeghe T,Dield L,de vries R,et al.Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,789(2):337-46. 被引量:1
  • 6de Brabander C,Vervaet C,Van Bortel L,Remon J P.Bioavailability of ibuprofen from hot-melt extruded mini-matrices[J].Int J Pharm,2004,271(1-2):77-84. 被引量:1
  • 7Klausner E A,Eyal S,Lavy E,et al.Novel levodopa gastroretentive dosage form:in vivo evaluation in dogs[J].J Control Release,2003,88(1):117-26. 被引量:1
  • 8Corey-Bloom J.Galantamine:a review of its use in Alzheimer's disease and vascular dementia[J].Int J Clin Pract,2003,57(3):219-223. 被引量:1
  • 9Farlow MR.Clinical pharmacokinetics of galantamine[J].Clin Pharmacokinet,2003,42(15):1383-1392. 被引量:1
  • 10Ellis JM.Cholinesterase inhibitors in the treatment of dementia[J].J Am Osteopath Assoc,2005,105(3):145-158. 被引量:1

共引文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部